About Us
About ICON
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development-from compound selection to Phase I-IV clinical studies.With 77 locations in more than 39 countries, ICON has the global resources, systems, and infrastructure in place to take on large, multi-center, multinational trials, but remains flexible enough to provide an individual, highly personalized service for locally managed projects.
CRO For Drug Development Products and Services
ICON offers a broad range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new treatments to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.
Insight Newsletters
- Late Phase & Outcomes Research
- Effective Use of Health Technology Assessment to Maximize Market Access: Start Early and Update Often
- International Variations And Similarities In Health Technology Assessment And Market Access
- Key Elements Of Observational Studies That Make Major Contributions To The Literature
In This Issue:
Proven Experience and Success
ICON is renowned for its core competency in project management underpinned by comprehensive and consistent processes which conform to ISO 9001:2000. We work with over 350 of the world's leading pharmaceutical, biotechnology, and medical device companies. To date, ICON teams have successfully conducted over 5,000 development projects and over 3,000 consultancy engagements across all major therapeutic areas. We are fully committed to delivering projects on time, on budget, and focus on results to achieve excellence in everything we do.ICON has been recognized as one of the world's leading Contract Research Organizations through a number of high profile industry awards:
- 2011 North American Growth Leadership Award
Frost & Sullivan 2011 - North American CRO Business Development Leadership Strategy
Frost and Sullivan, Best Practice Awards, Jan 2009 - ICON Is Rated One of Top Three CROs
CenterWatch US Investigative Site Survey 2009 - Clinical Research Company of the Year 2008
Pharmatimes, Clinical Research Awards, Jan 2009 - North American CRO Business Development Leadership Strategy
Frost and Sullivan, Best Practice Awards, Jan 2009 - Leading CRO for International Project Execution
Lehman Brothers Equity Research, R&D Managers Survey 2007
- Sponsors' Favorite CRO to work with
Thomson CenterWatch/William Blair, Sponsor Survey 2007
- Sponsors' Favorite Full Service CRO
Thomson CenterWatch/William Blair, Sponsor Survey 2007
- North American Pharmaceutical & Biotechnology Service Provider of the Year
Frost & Sullivan, Best Practice Awards 2007
Contact Information:
Americas
ICON Clinical Research
212 Church Road
North Wales, PA 19454
Tel: +1 215 616 3286
Fax: +1 215 240 6301
Website: www.iconplc.com
Contact: Erica Hill
Email: erica.hill@iconplc.com
ICON plc
South County Business Park
Lepardstown
Dublin 18
Ireland
Tel: +353 1 291 2000
Fax: +353 1 291 2700
Contact: Susan Dempsey
Email: susan.dempsey@iconplc.com
Website: www.iconplc.com
Contact Information
ICON
212 Church Road
North Wales, PA 19454
UNITED STATES
Phone: 215-616-3000
Fax: 215-699-6288
Contact: Erica Hill
Company Capabilities
- PDx-POP Software: Pharmacokinetic Modeling & Pharmacokinetic Analysis
- IMRA: ICOLabs Medical Review Application
- Transplant & Immunology Clinical Trials
- MIRA: Medical Image Review And Analysis
- Cariovascular Clinical Trials
- Infectious Disease And Vaccines Clinical Trials
- ICOPhone ePRO: Real-Time Patient Data Application
- NONMEM®: Nonlinear Mixed Effects PK/PD Modeling Tool
- IKE: Image-based Knowledge Management Portal
- ICOPhone: Interactive Voice & Web Response System
- Metabolic Disorders & Endocrine Clinical Trials
- Biosimilars / Follow-on Biologics Services
- Gastronintestinal Clinical Trials
- Central Nervous System Clinical Studies
- Oncology Clinical Trials & Studies
- ICOSpeedRead: Independent Image Review Analysis System
- ICON Medical Imaging
- ICON Development Solutions
- ICON Contracting Solutions
- Clinical Research: Phase IIb - IV Clinical Trials
- ICON Central Laboratories
- Preclinical / Phase I
- Phase II – IIIb
- Late Phase
- Laboratories
- Imaging
- Staffing
Featured Articles
- ICON Announces Peter Gray To Retire As CEO
- ICON Acquires Firecrest Clinical To Enhance Investigator Site Performance
- Excellence In Biomarkers
- Saccadic Eye Movements and Pupillometry Help Characterize Pharmacodynamic Drug Effects
- ICON Announces ICONIK - An Integrated Solution Providing Sponsors & CRO Teams A Single View of Study Information
- International Variations And Similarities In Health Technology Assessment And Market Access
- Key Elements Of Observational Studies That Make Major Contributions To The Literature
- ICON Selected By Pfizer As A Global Strategic Partner For Clinical Research And Development
- ICON Pharmaceutical Development Services Expands With A New Office In Shanghai
- Effective Use of Health Technology Assessment to Maximize Market Access: Start Early and Update Often
- ICON Forms Strategic Alliance With Boston Clinical Research Institute
- ICON Releases NONOMEM 7.2 For Pharmacokinetic And Pharmacodynamic Data Analysis
- ICON and ACRONET Sign Alliance Agreement For Clinical Development
- ICON Continues Asia-Pacific Expansion With New Office Opening In Shanghai And Senior Appointments In The Region
- ICON Appoints Dr. Anthony Priestley as Medical Director, Clinical Pharmacology
- ICON Acquires Oxford Outcomes
- ICON Insight: Navigating The New Era Of Reform And Revitalization: Japan
- FDA Expectations On Drug-Induced Liver Injury (DILI) And An Approach To Detecting And Monitoring
- ICON Launches Innovative Safety Application To Trend And Graph Laboratory Values
- ICON And Fountain Medical Development (FMD) Announce Opening Of Laboratory Facility In China
- ICON Opens Purpose-Built, Hospital Based Translational Medicine Unit In Manchester
- Bristol-Myers Squibb Signs Agreements With ICON And PAREXEL To Support Greater Efficiencies In Clinical Development
- ICON Clinical Research Announces The Appointment Of A Vice President And Global Head For The Infectious Diseases Therapeutic Area Group
- ICON Launches Innovative Safety Application To Trend And Graph Laboratory Values
- New ePRO Module Reduces Implementation Timelines For Collection Of Patient Data
- Lilly Selects ICON To Manage Its Clinical Data Management Business Outside The U.S.
- ICON Opens Full Service Central Laboratory In India
- ICON Named 2007 North American Pharmaceutical And Biotechnology Service Provider Of The Year
- ICON Named 'Favorite Contract Research Organization' By Pharmaceutical And Biotech Firms
- ICON Medical Imaging Launches New Service To Boost Reliability Of Cardiology Studies
- ICON Medical Imaging Launches New Cardiac Echocardiography Analysis Software
- ICON Identified As Leading CRO For International Project Execution By R&D Managers
- ICON Development Solutions Boosts Pharmacokinetic And Pharmacodynamic Expertise With New Appointments
- Safety First: The Impact Of New Regulations On Clinical Development
- ICON Selected To Manage Lilly Clinical Trial Site Set Up And Monitoring In Europe
- ICON Named A Favourite Contract Research Organisation By Pharmaceutical And Biotechnology Firms
- ICON Receives High Ranking In Independent Industry Survey
- New Safety Regulations Drive Greater Need For Resources And Expertise At Every Stage Of Clinical Development
- ICON Insight: Imaging And Cardiology
- ICON Insight: Pharmacodynamic Models In Phase I Clinical Trials — A Dynamic Approach
- ICON Partners With PHT For Handheld Electronic Patient Reported Outcomes Solutions
- ICON Insight: Leveraging Patient Registries To Assess Safety And Product Performance In The Post-Approval Arena
- The Driving Force Of Technology
- Adaptive Trial Designs In Late Phase Drug Development
- Advanced Science And The Art Of Letting Go: Considerations In Transferring Cytometric Assays From The Bench To A Central Laboratory
- Clinical Trials In Diabetes: Challenges In Patient Recruitment
- Patient Registries: A New Gold Standard For Real World Research
- A Dynamic Approach To Models In Phase I
- Symmetrical Data Management: The Development Of Data Management Metrics For Practical Use
- FDA Guidance Focuses On Cancer Trial Endpoints
- User Testing: Delivering Quality In PIL User Testing
- User Testing ... Time Is Running Out
- ICON Insight: Biotechnology: Delivering On The Promise
- ICON Insight: Enhancing Patient Recruitment: How Sites, Sponsors, And CROs Can Interact More Effectively